Global Herbal Nanomedicine Market Overview
Herbal Nanomedicine Market size was valued at USD 6.58 billion in 2023. The Herbal Nanomedicine Market industry is projected to grow from USD 7.23 billion in 2024 to USD 14.95 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.55% during the forecast period (2024 - 2032).
The factors that are driving the growth of the global market are the increasing demand for natural and herbal-based nanomedicine and growing geriatric population.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Herbal Nanomedicine Market Trends
Increasing demand for natural and herbal-based nanomedicine
The burgeoning demand for natural and herbal-based nanomedicine is acting as a potent catalyst for the exponential growth of the herbal nanomedicine market. This surge is propelled by several interconnected factors. For instance, herbal medicines are becoming more popular due to their effectiveness in treating various diseases with minimal side effects. Also, herbal medicines provide fewer adverse effects as compared with modern medicines. There are several herbal medicines that are extracted with nanotechnology and are manufactured by several companies, providing immense advantages. For instance, Herbalife (US) manufactures Immunoturmeric, is developed with raw materials cultivated by turmeric farmers in the Indonesia’s Central Java region. Curcumin, a compound found in turmeric, has been widely reported to help manage metabolic syndrome and inflammatory conditions. Despite its numerous advantages, curcumin is difficult to incorporate into commercial products, owing to its low water solubility, rapid metabolism by enzymes in the body, and low bioavailability.
Moreover, the growing geriatric population represents a significant driver for the herbal nanomedicine market. As people age around the world, there is an increase in age-related cognitive decline and neurological conditions like Alzheimer's disease and dementia. Herbal nanomedicines that have shown promising early signs of clinical efficacy in the symptomatic therapy of Alzheimer's disease (AD). The elderly population seeks solutions to maintain cognitive function and overall brain health, resulting in increased demand for herbal-based nanomedicine supplements and medications. Furthermore, the increasing geriatric population in North America, Europe, and Asia-Pacific is fueling the market growth. As per America’s Health Rankings, approximately 58 million adults ages 65 and older were living in the US in 2022. According to the European Commission, there were 448.8 million people, and more than one fifth of them were aged 65 years and over by January 2023.
Thus, the Herbal Nanomedicine Market is expanding due to growing geriatric population and lack of awareness associated with herbal nanomedicine.
Herbal Nanomedicine Market Segment Insights
Herbal Nanomedicine Market Type Insights
Based on type, the Herbal Nanomedicine Market is segmented into polymeric herbal nanoparticles, solid lipid nanoparticles, phytosomes, nano-micelles, self-nano emulsifying drug delivery system, nanofibers, and others. The polymeric herbal nanoparticles segment accounted for the largest market in 2023, and self-nano emulsifying drug delivery system segment is anticipated to be the fastest-growing for the forecast period of 2024–2032. The market for herbal nanoparticles is growing drastically, fueled by rising consumer demand for natural plus effective health explanations. The major key trends driving this growth is the rising interest in integrating traditional herbal remedies with cutting-edge nanotechnology. This integration not only manages the therapeutic benefits of herbal compounds but also develops their effectiveness through advanced delivery systems. Research and development in this area is improving, with numerous studies demonstrating the potential of herbal nanoparticles in treating a variety of ailments, ranging from chronic diseases to infections as well as inflammatory conditions.
Herbal Nanomedicine Market Source Insights
Based on source, the Herbal Nanomedicine Market has been segmented into ginseng, turmeric, aloe vera, ginger, and others. Ginseng held the largest market share in 2023, and turmeric is anticipated to register the highest CAGR from 2024 to 2032. The herbal nanomedicine market is experiencing drastic growth, driven by the increased therapeutic efficacy plus bioavailability of herbal compounds through nanotechnology. Major key ingredients such as ginseng, turmeric, aloe vera, and ginger are at the lead of this market growth. Ginseng nanoparticles are used for their potent antioxidant as well as anti-inflammatory roles, which improve cognitive function and immune response. Turmeric, with its active component curcumin, and curcumin benefits from nano formulations that enhance its solubility and absorption, thereby boosting its anti-inflammatory and anticancer effects. Aloe vera nanoparticles boost the bioavailability of compounds, making it effective in wound properties.
FIGURE 2: GLOBAL HERBAL NANOMEDICINE MARKET, BY SOURCE, 2023 & 2032 (USD BILLION)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Herbal Nanomedicine Market Application Insights
Based on application, the herbal nanomedicine market is segmented into cancer, cardiovascular diseases, neurological disorders, and others. Cancer held the largest market share in 2023 and are anticipated to register the highest CAGR during the forecast period. The herbal nanomedicine market is undergoing drastic growth, specifically in cancer treatment. Utilizing herbal compounds such as curcumin which is extracted from turmeric and catechins from green tea, these nanomedicines improve the delivery, stability, and efficacy of anti-cancer agents. Nanoparticles improve targeted drug delivery, minimizing side effects and maximizing therapeutic impact. This novel approach offers promising advancements in oncology, blending natural remedies with cutting-edge nanotechnology for improved cancer care treatments. Furthermore, the increasing prevalence of cancer is driving market growth. According to the National Cancer Institute, cancer is one of the world's leading causes of death. In 2022, there were nearly 20 million new cancer cases and 9.7 million deaths worldwide. By 2040, the annual number of new cancer cases is expected to reach 29.9 million, with 15.3 million cancer-related deaths.
Herbal Nanomedicine Market Regional Insights
By region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest market share of over 38.36% in 2023, owing to the growing preference for natural and organic products, especially among the younger generation, increasing research and development activities in the field of nanomedicine, and presence of established players in the herbal medicine and nanotechnology industries.
Further, the major countries studied are: The US, Canada, Brazil, Germany, France, the UK, Italy, Spain, China, India, Japan, South Korea, and Australia.
FIGURE 3: GLOBAL HERBAL NANOMEDICINE MARKET, BY REGION, 2023 & 2032 (USD BILLION)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The Europe herbal nanomedicine market shows significant growth during the forecast year, i.e., 2024–2032, owing to the growing preference for natural and herbal remedies among European consumers, presence of established herbal medicine manufacturers in Europe, and regulatory framework is relatively supportive of herbal medicines, providing a conducive environment for the development and commercialization of herbal nanomedicines. For instance, Indena S.p.A. (Italy) and Nanoceutical Solutions (US), which has presence in UK and Ireland offer herbal nanomedicine products. Nanoceutical Solutions offers a range of supplements formulated to tackle a variety of health concerns, from nanoglutathione to nanoturmeric curcumin. Incorporating effective supplements and antioxidants (in addition to healthy lifestyle choices and diet) can go a long way toward combating free radicals that can damage bodies, both inside and out.
The Asia-Pacific herbal nanomedicine market is the fastest-growing region during the forecast period owing to a growing geriatric population. This is because older adults often face chronic health conditions such as arthritis, cardiovascular diseases, diabetes, and cognitive decline. Many seek natural remedies to manage these conditions due to concerns about side effects from conventional pharmaceuticals. Furthermore, as per the Asia-Pacific Report on Population Ageing 2022, there were approximately 670 million people aged 60 or older in Asia-Pacific in 2022. Also, it has been estimated that the number will double to approximately 1.3 billion people by 2050 in Asia-Pacific. Moreover, China herbal nanomedicine market held the largest market share in 2023, and India Herbal nanomedicine market is the fastest growing market in the Asia-Pacific region.
Herbal Nanomedicine Market Key Market Players & Competitive Insights
The Herbal Nanomedicine Market is extremely competitive, with players competing and investing heavily in research & development to gain a significant market share. The market is moderately fragmented with high competition in the market, increasing collaborative partnerships, and other strategic decisions to achieve operational efficiency. The growth of prominent industry players is dependent on various factors, such as market conditions, government support, and industry development. It is also projected that a rise in the investments for new product launches, expanding home healthcare, and growing technological advancements will also boost the market's growth in the upcoming future.
Indena S.p.A. (Italy) is a industry leader in the development and production of premium active ingredients for the health food and pharmaceutical sectors. Specifically, Indena provides safe, well-supported by cutting-edge human research botanical extracts from edible plants that have undergone thorough phytochemical characterisation. It has presence across North America, Europe, Asia and Oceania, South America, Middle East & Africa.
Key Companies in the Herbal Nanomedicine Market includes.
- Evolu Research (US)
- Codeage (US)
- Nutriherbs (India)
- Basic Brands Inc. (US)
- Herbalife International of America, Inc. (US)
- Indena S.p.A. (Italy)
- Nanoceutical Solutions (US)
- Vibdrugs Biosciences (India)
- One Planet Nutrition (US)
- OIC New (Vietnam)
Herbal Nanomedicine Market Segmentation
Herbal Nanomedicine Market Type Outlook
- Polymeric Herbal Nanoparticles
- Solid Lipid Nanoparticles
- Phytosomes
- Nano-Micelles
- Self-nano Emulsifying Drug Delivery System
- Nanofibers
- Others
Herbal Nanomedicine Market Type Outlook
- Ginseng
- Turmeric
- Aloe Vera
- Ginger
- Others
Herbal Nanomedicine Market Application Outlook
Herbal Nanomedicine Market Regional Outlook
-
North America
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
-
Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
-
Rest of the World
- Middle East & Africa
- South America
Report Attribute/Metric |
Details |
Market Size 2023 |
USD 6.58 billion |
Market Size 2024 |
USD 7.23 billion |
Market Size 2032 |
USD 14.95 billion |
Compound Annual Growth Rate (CAGR) |
8.55% (2024-2032) |
Base Year |
2023 |
Forecast Period |
2024-2032 |
Historical Data |
2019 to 2022 |
Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Type, Source, Application, and Region |
Geographies Covered |
North America, Europe, Asia Pacific, and Rest of the World |
Countries Covered |
The US, Canada, Brazil, Germany, France, the UK, Italy, Spain, China, India, Japan, South Korea, Australia. |
Key Companies Profiled |
Evolu Research (US), Codeage (US), Nutriherbs (India), Basic Brands Inc. (US), Herbalife International of America, Inc. (US), Indena S.p.A. (Italy), Nanoceutical Solutions (US), Vibdrugs Biosciences (India), One Planet Nutrition (US), and OIC New (Vietnam) |
Key Market Opportunities |
·      Ongoing research and clinical trials on herbal nanomedicine |
Key Market Drivers |
·      Increasing demand for natural and herbal-based nanomedicine ·      Growing geriatric population |
Frequently Asked Questions (FAQ) :
The Herbal Nanomedicine Market is anticipated to reach 14.95 billion by 2032 at a CAGR of 8.55% during the forecast period of 2024-2032.
The US held 82.20% share of North America for Herbal nanomedicine market in 2023.
The Herbal Nanomedicine Market is expected to grow at an 8.55% CAGR during the forecast period from 2024 to 2032.
The North America region market held the largest market share in the global herbal nanomedicine market.
The key players include Evolu Research (US), Codeage (US), Nutriherbs (India), Basic Brands Inc. (US), Herbalife International of America, Inc. (US), Indena S.p.A. (Italy), Nanoceutical Solutions (US), Vibdrugs Biosciences (India), One Planet Nutrition (US), and OIC New (Vietnam) and among others.
The polymeric herbal nanoparticles of type segment led the Herbal Nanomedicine Market in 2023.
The ginseng segment had the largest market in 2023 with a market share of around 22.08%.